CIK 0001137883 · Non-accelerated filer<br>Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 207273918
- Phone
- 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-01 | Naor Nir Director | Grant or award | +30,666 | 31,465 | ||
| 2025-01-01 | Lindborg Stacy Director | Grant or award | +20,000 | 48,229 | ||
| 2025-01-01 | HARTOUNIAN HARTOUN EVP, Chief Operating Officer | Grant or award | +50,000 | 52,000 | ||
| 2025-01-01 | Bairu Menghisteab Director | Grant or award | +24,000 | 24,000 | ||
| 2025-01-01 | ARBEL IRIT Director | Grant or award | +30,666 | 41,054 | ||
| 2024-10-01 | Lebovits Chaim President & CEO | Purchase | +1,836 | $3.43 | $6K | 80,960 |
| 2024-09-30 | Lebovits Chaim President & CEO | Purchase | +22,000 | $0.23 | $5K | 1,186,865 |
| 2024-07-19 | Dagher Ibrahim B. Chief Medical Officer | Sale | −63,000 | $0.35 | $22K | 0 |
| 2024-06-24 | HARTOUNIAN HARTOUN EVP, Chief Operating Officer | Grant or award | +30,000 | 30,000 | ||
| 2024-06-24 | HARTOUNIAN HARTOUN EVP, Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2024-05-28 | Lebovits Chaim President & CEO | Purchase | +15,000 | $0.52 | $8K | 1,164,865 |
| 2024-05-28 | Lebovits Chaim President & CEO | Grant or award | +15,000 | $0.52 | $8K | 1,164,865 |
| 2024-05-22 | Lebovits Chaim President & CEO | Purchase | +25,000 | $0.64 | $16K | 1,149,865 |
| 2024-05-22 | Lebovits Chaim President & CEO | Grant or award | +25,000 | $0.64 | $16K | 1,149,865 |
| 2024-05-21 | Lebovits Chaim President & CEO | Purchase | +25,000 | $0.58 | $14K | 1,124,865 |
| 2024-05-21 | Lebovits Chaim President & CEO | Grant or award | +25,000 | $0.58 | $14K | 1,124,865 |
| 2024-05-13 | Lebovits Chaim President & CEO | Purchase | +10,000 | $0.49 | $5K | 1,099,865 |
| 2024-05-13 | Lebovits Chaim President & CEO | Grant or award | +10,000 | $0.49 | $5K | 1,099,865 |
| 2024-05-11 | Lebovits Chaim President & CEO | Purchase | +10,000 | $0.47 | $5K | 1,089,865 |
| 2024-05-11 | Lebovits Chaim President & CEO | Grant or award | +10,000 | $0.47 | $5K | 1,089,865 |
Page 2 of 7 · 127 trades